Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Living Cell Technologies Ltd. (LVCLF)
OTHER OTC:LVCLF
Holding LVCLF?
Track your performance easily
LVCLF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.02
Previous Close$0.01
Volume2.00K
Average Volume (3M)N/A
Market Cap
$7.38M
Enterprise Value$4.70M
Total Cash (Recent Filing)AU$4.24M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta2.33
Next Earnings
Feb 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares OutstandingN/A
10 Day Avg. Volume200
30 Day Avg. VolumeN/A
Standard Deviation0.30
R-Squared0.00818
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)3066.44
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Living Cell Technologies Ltd. News
PremiumCompany Announcements
Algorae Pharmaceuticals’ AI-168 Shows Promising Results
PremiumCompany Announcements
Algorae Pharmaceuticals Strengthens Board with Industry Expert
PremiumCompany Announcements
Algorae Pharmaceuticals Expands Pipeline with AI-Driven Targets
PremiumCompany Announcements
Algorae Pharmaceuticals Plans Major Securities Issuance
PremiumCompany Announcements
Algorae Pharmaceuticals Streamlines Operations with OTCQB ExitPremiumCompany Announcements
Living Cell Technologies Announces Director’s Interest Change
PremiumCompany Announcements
Algorae Pharmaceuticals Plans Major Securities Issuance
PremiumCompany Announcements
Algorae Pharmaceuticals Secures Shareholder Support at AGMOptions Prices
Currently, No data available
---
Ownership Overview
5.79%
Insiders
― Other Institutional Investors
94.21% Public Companies and
Individual Investors
LVCLF FAQ
What was Living Cell Technologies Ltd.’s price range in the past 12 months?
Living Cell Technologies Ltd. lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Living Cell Technologies Ltd.’s market cap?
Currently, no data Available
When is Living Cell Technologies Ltd.’s upcoming earnings report date?
Living Cell Technologies Ltd.’s upcoming earnings report date is Feb 20, 2025 which is in 59 days.
How were Living Cell Technologies Ltd.’s earnings last quarter?
Living Cell Technologies Ltd. released its earnings results on Aug 30, 2024. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Living Cell Technologies Ltd. overvalued?
According to Wall Street analysts Living Cell Technologies Ltd.’s price is currently Overvalued.
Does Living Cell Technologies Ltd. pay dividends?
Living Cell Technologies Ltd. does not currently pay dividends.
What is Living Cell Technologies Ltd.’s EPS estimate?
Living Cell Technologies Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Living Cell Technologies Ltd. have?
Living Cell Technologies Ltd. has 1,687,394,800 shares outstanding.
What happened to Living Cell Technologies Ltd.’s price movement after its last earnings report?
Living Cell Technologies Ltd. reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Living Cell Technologies Ltd.?
Currently, no hedge funds are holding shares in LVCLF
---
Living Cell Technologies Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-60.70%
Trailing 12-Months
Asset Growth
-23.95%
Trailing 12-Months
Company Description
Living Cell Technologies Ltd.
Living Cell Technologies Ltd. is a biotechnology company. It engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company was founded by Robert Bartlett Elliot and David Collinson in 1987 and is headquartered in Auckland, New Zealand.
---
Capricor Therapeutics
―
Inovio Pharmaceuticals
―
Genetic Technologies
―
Brainstorm Cell Therapeutics
―
---